Inspire Medical Systems, Inc. (NYSE:INSP) Shares Purchased by Diversified Trust Co

Diversified Trust Co increased its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 26.6% in the first quarter, Holdings Channel reports. The firm owned 5,471 shares of the company’s stock after purchasing an additional 1,150 shares during the period. Diversified Trust Co’s holdings in Inspire Medical Systems were worth $1,175,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently bought and sold shares of INSP. Baillie Gifford & Co. raised its stake in shares of Inspire Medical Systems by 6,846.9% in the fourth quarter. Baillie Gifford & Co. now owns 1,229,879 shares of the company’s stock worth $250,194,000 after purchasing an additional 1,212,175 shares during the last quarter. Wellington Management Group LLP raised its position in Inspire Medical Systems by 46.4% during the 4th quarter. Wellington Management Group LLP now owns 1,430,266 shares of the company’s stock worth $290,959,000 after buying an additional 453,294 shares during the last quarter. Frontier Capital Management Co. LLC lifted its stake in Inspire Medical Systems by 105.2% during the 4th quarter. Frontier Capital Management Co. LLC now owns 742,046 shares of the company’s stock valued at $150,954,000 after acquiring an additional 380,362 shares during the period. Jennison Associates LLC boosted its holdings in shares of Inspire Medical Systems by 648.2% in the 4th quarter. Jennison Associates LLC now owns 304,886 shares of the company’s stock valued at $62,023,000 after acquiring an additional 264,139 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Inspire Medical Systems in the fourth quarter worth $49,116,000. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Insider Transactions at Inspire Medical Systems

In other news, CFO Richard Buchholz sold 15,000 shares of the firm’s stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $230.03, for a total value of $3,450,450.00. Following the transaction, the chief financial officer now directly owns 28,271 shares of the company’s stock, valued at $6,503,178.13. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 4.10% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently issued reports on INSP. Mizuho restated a “buy” rating and set a $250.00 target price on shares of Inspire Medical Systems in a research report on Wednesday, March 27th. Royal Bank of Canada initiated coverage on Inspire Medical Systems in a research note on Friday, April 19th. They issued an “outperform” rating and a $285.00 target price on the stock. Morgan Stanley began coverage on Inspire Medical Systems in a research report on Tuesday, March 19th. They set an “overweight” rating and a $250.00 price target for the company. Bank of America lowered their price objective on Inspire Medical Systems from $225.00 to $185.00 and set a “neutral” rating on the stock in a research report on Monday, June 3rd. Finally, Stifel Nicolaus cut their target price on shares of Inspire Medical Systems from $210.00 to $170.00 and set a “hold” rating for the company in a report on Monday, June 24th. Five investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $251.20.

Inspire Medical Systems Stock Up 3.7 %

Shares of Inspire Medical Systems stock opened at $138.75 on Tuesday. Inspire Medical Systems, Inc. has a twelve month low of $123.27 and a twelve month high of $330.00. The firm’s 50-day moving average price is $177.05 and its 200 day moving average price is $192.52.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Tuesday, May 7th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.63) by $0.29. Inspire Medical Systems had a negative return on equity of 2.82% and a negative net margin of 2.38%. The firm had revenue of $164.01 million for the quarter, compared to analyst estimates of $161.41 million. During the same period in the previous year, the company posted ($0.53) earnings per share. The business’s revenue was up 28.2% on a year-over-year basis. As a group, analysts anticipate that Inspire Medical Systems, Inc. will post 0.16 earnings per share for the current year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.